Literature DB >> 28811573

Simultaneous Separation of Actinium and Radium Isotopes from a Proton Irradiated Thorium Matrix.

Tara Mastren1, Valery Radchenko1,2, Allison Owens3, Roy Copping3, Rose Boll3, Justin R Griswold3, Saed Mirzadeh3, Lance E Wyant3, Mark Brugh1, Jonathan W Engle1,4, Francois M Nortier1, Eva R Birnbaum1, Kevin D John1, Michael E Fassbender5.   

Abstract

A new method has been developed for the isolation of 223,224,225Ra, in high yield and purity, from a proton irradiated 232Th matrix. Herein we report an all-aqueous process using multiple solid-supported adsorption steps including a citrate chelation method developed to remove >99.9% of the barium contaminants by activity from the final radium product. A procedure involving the use of three columns in succession was developed, and the separation of 223,224,225Ra from the thorium matrix was obtained with an overall recovery yield of 91 ± 3%, average radiochemical purity of 99.9%, and production yields that correspond to physical yields based on previously measured excitation functions.

Entities:  

Year:  2017        PMID: 28811573      PMCID: PMC5558011          DOI: 10.1038/s41598-017-08506-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  12 in total

1.  Separation of radium from barium by the use of an ion-exchange column procedure.

Authors:  E R TOMPKINS
Journal:  J Am Chem Soc       Date:  1948-10       Impact factor: 15.419

2.  Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200 MeV.

Authors:  J W Weidner; S G Mashnik; K D John; F Hemez; B Ballard; H Bach; E R Birnbaum; L J Bitteker; A Couture; D Dry; M E Fassbender; M S Gulley; K R Jackman; J L Ullmann; L E Wolfsberg; F M Nortier
Journal:  Appl Radiat Isot       Date:  2012-07-11       Impact factor: 1.513

3.  Production of actinium-225 for alpha particle mediated radioimmunotherapy.

Authors:  Rose A Boll; Dairin Malkemus; Saed Mirzadeh
Journal:  Appl Radiat Isot       Date:  2005-01-28       Impact factor: 1.513

4.  Large scale accelerator production of 225Ac: Effective cross sections for 78-192MeV protons incident on 232Th targets.

Authors:  J R Griswold; D G Medvedev; J W Engle; R Copping; J M Fitzsimmons; V Radchenko; J C Cooley; M E Fassbender; D L Denton; K E Murphy; A C Owens; E R Birnbaum; K D John; F M Nortier; D W Stracener; L H Heilbronn; L F Mausner; S Mirzadeh
Journal:  Appl Radiat Isot       Date:  2016-09-28       Impact factor: 1.513

5.  Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.

Authors:  Fu-Min Su; Paul Beaumier; Don Axworthy; Robert Atcher; Alan Fritzberg
Journal:  Nucl Med Biol       Date:  2005-10       Impact factor: 2.408

6.  A Radium-223 microgenerator from cyclotron-produced trace Actinium-227.

Authors:  Diane S Abou; Juile Pickett; John E Mattson; Daniel L J Thorek
Journal:  Appl Radiat Isot       Date:  2016-11-04       Impact factor: 1.513

7.  First Measurement of the Atomic Electric Dipole Moment of (225)Ra.

Authors:  R H Parker; M R Dietrich; M R Kalita; N D Lemke; K G Bailey; M Bishof; J P Greene; R J Holt; W Korsch; Z-T Lu; P Mueller; T P O'Connor; J T Singh
Journal:  Phys Rev Lett       Date:  2015-06-09       Impact factor: 9.161

8.  Selenium-72 formation via nat Br(p,x) induced by 100 MeV protons: steps towards a novel 72Se/72As generator system.

Authors:  B Ballard; D Wycoff; E R Birnbaum; K D John; J W Lenz; S S Jurisson; C S Cutler; F M Nortier; W A Taylor; M E Fassbender
Journal:  Appl Radiat Isot       Date:  2012-02-01       Impact factor: 1.513

9.  Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.

Authors:  Paul G Kluetz; William Pierce; V Ellen Maher; Hui Zhang; Shenghui Tang; Pengfei Song; Qi Liu; Martin T Haber; Eldon E Leutzinger; Ali Al-Hakim; Wei Chen; Todd Palmby; Elleni Alebachew; Rajeshwari Sridhara; Amna Ibrahim; Robert Justice; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2013-11-04       Impact factor: 12.531

10.  Functionalized NaA nanozeolites labeled with 224,225Ra for targeted alpha therapy.

Authors:  Agata Piotrowska; Edyta Leszczuk; Frank Bruchertseifer; Alfred Morgenstern; Aleksander Bilewicz
Journal:  J Nanopart Res       Date:  2013-10-31       Impact factor: 2.253

View more
  6 in total

1.  Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.

Authors:  Valery Radchenko; Alfred Morgenstern; Amir R Jalilian; Caterina F Ramogida; Cathy Cutler; Charlotte Duchemin; Cornelia Hoehr; Ferrid Haddad; Frank Bruchertseifer; Haavar Gausemel; Hua Yang; Joao Alberto Osso; Kohshin Washiyama; Kenneth Czerwinski; Kirsten Leufgen; Marek Pruszyński; Olga Valzdorf; Patrick Causey; Paul Schaffer; Randy Perron; Samsonov Maxim; D Scott Wilbur; Thierry Stora; Yawen Li
Journal:  J Nucl Med       Date:  2021-07-22       Impact factor: 11.082

2.  Selective biosorption of thorium (IV) from aqueous solutions by ginkgo leaf.

Authors:  Yaoyao Huang; Yang Hu; Lvcun Chen; Tao Yang; Hanfang Huang; Runping Shi; Peng Lu; Chenghua Zhong
Journal:  PLoS One       Date:  2018-03-06       Impact factor: 3.240

3.  Separation of 103Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide 103mRh.

Authors:  Tara Mastren; Valery Radchenko; Philip D Hopkins; Jonathan W Engle; John W Weidner; Roy Copping; Mark Brugh; F Meiring Nortier; Eva R Birnbaum; Kevin D John; Michael Ernst-Heinrich Fassbender
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

Review 4.  An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth.

Authors:  Alfred Morgenstern; Christos Apostolidis; Clemens Kratochwil; Mike Sathekge; Leszek Krolicki; Frank Bruchertseifer
Journal:  Curr Radiopharm       Date:  2018

5.  Guest Edited Collection: Radioisotopes and radiochemistry in health science.

Authors:  Michael E Fassbender
Journal:  Sci Rep       Date:  2020-01-10       Impact factor: 4.379

6.  Feasibility of a novel photoproduction of 225Ac and 227Th with natural thorium target.

Authors:  Kwangho Ju; Yonghee Kim
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.